Track topics on Twitter Track topics that are important to you
As it named a new president, Diplomat reported Q2 results that showed increased revenue, but highlighted the margin pressure it’s seeing as the result of DIR fees.
Original Article: Diplomat names new president, reports Q2 earningsNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...